Across 2,200 entries, Marex Group (MRX) reports $25.7B in holdings.
Marex Group Ltd (MRX) has reported its Form 13F holdings, detailing 2,200 investment entries valued at $25,684,182,204. The filing, accepted by the SEC on November 16, 2026, also lists five other included managers, distinguishing it as a "13F Holdings Report." This report provides an overview of the institutional investment manager's substantial portfolio.
Conditional 2.005% monthly coupons come with up to 100% principal risk on Marex Group (MRX) notes.
Marex Group has priced a $200,000 offering of autocallable contingent income buffered notes due May 18, 2028. These notes are linked to the performance of Interactive Brokers Group (IBKR) and Blackstone Inc. (BX) common stocks, offering a monthly coupon of 2.005% if both stocks meet their triggers. However, investors face up to 100% principal loss if the notes are not called and the worst-performing stock falls significantly below its 25% buffer.
Is Marex Group (MRX) Eyeing A Bigger Digital Assets Push?
Marex Group (MRX) is reportedly in talks to acquire Nomura's Laser Digital crypto arm, indicating a potential expansion into digital assets. This move would integrate with Marex's existing market infrastructure but would also test the company's ability to grow higher-margin earnings without overstretching its balance sheet. Investors are watching for a formal sale decision to evaluate the transaction's financial implications and management's integration strategy.
Marex Group (MRX) Stock Looks Overvalued Given Its Excess Returns Outlook
Marex Group's stock has surged 112.4% over the past year, leading to concerns that its current valuation may be overextended beyond what its underlying business returns can justify. An Excess Returns model suggests the intrinsic value is substantially below the current share price of $71.68, despite strong Q3 2026 results. Analyst narratives present both bull and bear cases, with the former seeing the stock as 12% undervalued due to higher-margin activities, and the latter as 62% overvalued due to rising funding costs.
Three lots of Marex Group (MRX) shares were sold by Paolo Tonucci under a prearranged trading plan.
Paolo Tonucci, Chief Strategist and CEO, Capital Markets at Marex Group Ltd (MRX), sold a total of 16,668 ordinary shares in three separate transactions on November 9, 2026. These sales, valued at approximately $1.14 million, were executed under a prearranged Rule 10b5-1 trading plan established on October 22, 2025. The shares were sold at weighted average prices ranging from $67.8914 to $69.4058 per share.
A director proposes selling 29,696 Marex (MRX) shares through Coutts & Co.
Robert Mark Pickering, a director at Marex Group Ltd, has filed a Form 144 notice proposing to sell 29,696 ordinary shares with an aggregate market value of approximately $2.20 million. The sale is scheduled for November 12, 2026, with Coutts & Co named as the broker. These shares were acquired through an IPO purchase, market purchases, and the vesting of restricted stock units.
Form 144 Marex Group Ltd For: 12 November By Investing.com
The article reports on a Form 144 filing by Marex Group Ltd on November 12, 2026. Form 144 is a notice filed with the SEC by an insider of a company to announce their intent to sell restricted stock. The content provides the filing information without further details on the transaction itself.
Marex Group Stock In Focus After Earnings Beat And Dividend Affirmation
Marex Group reported strong net income of US$398 million for the nine months ending September 30, 2026, and affirmed a quarterly dividend of US$0.1600 per share. This performance suggests the company is balancing balance sheet strength with capital returns to shareholders, despite ongoing operational risks such as credit events and rising funding costs. Analysts project continued revenue and earnings growth for Marex Group by 2029, with an estimated 11% potential upside to its current stock price.
Nomura Weighs Sale of Laser Digital Crypto Unit, Marex Among Potential Buyers: 10 outlets compared
Nomura is reportedly considering selling its Zurich-based Laser Digital Holdings AG crypto unit, with Marex Group among the potential buyers. This move follows losses in Nomura's European operations, which experienced their fourth consecutive quarterly loss. While Nomura declined to comment, the exploration of a sale suggests a reevaluation of its crypto business strategy.
Is Marex Group (MRX) Undervalued On Stronger Earnings And Its Dividend Affirmation?
Marex Group (MRX) recently reported net income of US$398 million for the nine months to September 30, 2026, a significant increase from US$222.4 million a year earlier, and affirmed a quarterly dividend of US$0.1600 per share. While the company's share price has seen a substantial year-to-date increase of 82.55%, momentum has cooled recently. Simply Wall St's analyst consensus suggests Marex Group is 15% undervalued with a fair value of $81.88, driven by stronger earnings and a shift towards higher-margin activities, although a discounted cash flow model suggests it might be overvalued at $53.22.
What Early Marex Group Buyers Saw Before A 81% Gain
Marex Group (NasdaqGS:MRX) saw an 81% gain for investors who bought shares on January 1, 2026. This performance was driven by Q3 2026 revenue of US$967.9 million and net income of US$120.2 million, supporting a bullish narrative of product expansion and acquisitions. However, current valuations at US$67.91 may already price in much of this growth, with bearish concerns about funding costs and compliance potentially capping future net margin expansion.
Six planned sales total 22,456 shares for Marex (MRX) President Simon Van Den Born.
Marex Group Ltd (MRX) President Simon Van Den Born sold 22,456 ordinary shares on November 5, 2026, across six transactions as part of a Rule 10b5-1 plan initiated on June 12, 2026. The sales were made at weighted-average prices ranging from $64.7773 to $69.3644 per share, totaling approximately $1.49 million. After these transactions, Van Den Born's direct holdings decreased to 1,432,620 ordinary shares.
Marex Group (MRX) Posts Record Q3 as Acquisitions Lift Revenue and Profit
Marex Group (MRX) reported record Q3 2026 results, driven by substantial gains in revenue and profit, largely attributed to recent acquisitions. The company is strategically focusing on structural growth areas like prediction markets and tokenization to diversify its product mix. This performance reinforces the investment thesis that Marex can scale infrastructure earnings through disciplined acquisitions, similar to larger market players.
Marex (MRX) Stock Could Be 32% Overvalued As Crypto Index Launch Expands
Marex Group (MRX) has seen its share price rise significantly over the past year, prompting questions about its current valuation. While the launch of institutional crypto indices could enhance its fee-driven revenue and capital efficiency, Simply Wall St's Excess Returns model suggests the stock may be 32% overvalued. Community narratives present mixed views, with some seeing infrastructure-led upside and others pointing to funding-related growing pains.
$1,000 notes from Marex (MRX) link conditional coupons to Microsoft, Micron and Mondelēz.
Marex Group Ltd is offering preliminary contingent-income notes with a $1,000 principal amount per Note, linked to the worst-performing stock among Mondelēz International, Microsoft Corporation, and Micron Technology. These senior unsecured obligations offer monthly coupons of at least 1.367% (16.404% per annum) if all three stocks close at or above 50% of their Initial Values, with missed coupons potentially paid later. At maturity, losses can reach 100% of the principal if the worst-performing stock declines by more than 50%.
Marex Group Q3 2026 Earnings Call Transcript
Marex Group reported a record third quarter in 2026, with revenue up 53% year-on-year to $743 million and adjusted profit before tax rising 75% to $176 million. The company's strategy of expanding capabilities through acquisitions like Levmet and Web Traders, and investing in new growth areas such as prediction markets and compute futures, has contributed to consistent earnings growth. Marex Group also maintains a strong balance sheet and is targeting 10-20% adjusted PBT growth in 2027.
Revenue rises 53% at Marex (MRX) as preliminary Q3 profit also climbs.
Marex Group Ltd (MRX) reported a significant financial performance for Q3 2026, with revenue increasing by 53% year-over-year to $743.2 million and profit after tax climbing 78% to $130.3 million. The company also announced a $0.16-per-share dividend payable December 2, 2026, and expressed confidence in achieving its 10-20% adjusted profit before tax growth target for 2027. This growth was broad-based across all four business segments, reflecting expanded capabilities, increased client activity, and contributions from recent acquisitions.
Marex Beats On Volatility-Fueled Market Making As Growth Accelerates, But Prime And Solutions Show The Limits Of The Record
Marex Group (NASDAQ: MRX) achieved its third consecutive record quarter, driven largely by volatility in metals trading which boosted market making revenue. While adjusted earnings and revenue significantly beat consensus estimates and showed accelerated growth, the Prime and Solutions segments experienced sequential setbacks. The company raised its long-term adjusted PBT margin aspiration to roughly 30% and expects 10-20% adjusted PBT growth in 2027, supported by a strong M&A pipeline, but faces challenges with capital constraints in Prime and eroding net interest income.
Marex Group Q3 26 Earnings Conference Call At 9:00 AM ET
Marex Group plc (MRX) is scheduled to host a conference call on November 5, 2026, at 9:00 AM ET to discuss its Q3 26 earnings results. Investors can access the live webcast through the provided link to listen to the discussion. The article also includes various related financial news and updates from other companies.
How Investors May Respond To Marex Group (MRX) Board Appointment
Marex Group (MRX) has appointed Kory Sorenson to its Board of Directors, a move expected to sharpen the company's focus on risk control and capital structuring given her extensive background in governance, capital markets, and risk oversight. Investors will likely assess how Sorenson's expertise influences Marex Group's investment narrative, particularly concerning its ability to manage debt and capital-intensive activities. While some analysts are optimistic about Marex Group's margin story, Sorenson's appointment could shift expectations around earnings trajectory and the overall financial health of the capital markets platform.
Marex Group (MRX) Adds A New Director, Is The Stock Fully Priced?
Marex Group (MRX) has appointed Kory Sorenson to its Board of Directors, effective November 2, 2026. The stock has seen significant gains this year, with a 126.27% total shareholder return over one year, prompting questions about its current valuation. While one narrative suggests the stock is 14% undervalued with a fair value of $79.88 due to M&A activity, another discounted cash flow analysis by Simply Wall St indicates the shares might be overvalued at $47.38.
Buyers of Marex (MRX)'s $250K notes earn no interest and risk losing all principal.
Marex Group Ltd is offering $250,000 in autocallable leveraged buffered notes linked to the performance of Ciena Corporation and Sandisk Corporation common stock. These notes pay no interest, and investors risk losing all principal if the worst-performing stock declines beyond a 40% buffer. The estimated initial value of the notes is $968.00 per note, which is less than the $1,000.00 public price.
Up to 100% principal loss is possible on Marex (MRX)'s proposed $1,000 index-linked notes.
Marex Group Ltd is proposing an offering of autocallable leveraged barrier notes linked to the Russell 2000 Index, with a principal amount of $1,000 per note. While the notes offer 150% upside participation if not called and the reference return is positive, investors face a 1-to-1 downside exposure if the index falls below a -25% barrier, leading to a possible 100% loss of principal. The notes do not pay interest, and payments are subject to Marex's credit risk.
Tied to Ciena and Sandisk, Marex (MRX) notes pay no interest and can lose all principal.
Marex Group Ltd (MRX) is offering autocallable leveraged buffered notes linked to the worst-performing stock of Ciena Corporation and Sandisk Corporation. These notes, with a principal of $1,000, offer a 74.00% call premium if both stocks are at or above 100% of their initial value on November 9, 2027. If not called, positive returns receive 300% participation, but losses beyond a -40.00% buffer are leveraged, potentially leading to a 100% loss of principal, and the notes pay no interest.
Three indices govern coupons on Marex (MRX)'s $315K notes; unredeemed notes can lose all principal.
Marex Group Ltd is offering $315,000 of issuer-callable contingent income barrier notes linked to the performance of the S&P 500, Russell 2000, and Nasdaq-100 indices, maturing on November 2, 2029. These notes offer an 11.8% annualized coupon, paid quarterly, but only if all three indices meet specific thresholds. A significant risk exists as unredeemed notes can lead to a 100% loss of principal if the worst-performing index falls below its barrier at final valuation.
Up to 90% of principal is at risk on Marex Group (MRX)'s proposed gold-linked notes.
Marex Group Limited has proposed capped leveraged buffered notes linked to SPDR Gold Shares, offering 2.00x upside participation capped at 33.00%. While the notes provide a 10% buffer against initial declines, losses beyond this threshold are one-for-one, potentially risking up to 90% of the principal amount. These senior unsecured obligations do not pay interest and are subject to Marex's credit risk, with an estimated initial value below the public price.
$1,000 S&P 500 notes from Marex (MRX) offer twice positive index returns at maturity, subject to a cap.
Marex Group Ltd is offering capped leveraged buffered notes linked to the S&P 500 Index, with a principal of $1,000 per Note and a December 5, 2028 maturity. These notes offer 200% upside participation for positive returns, capped at a maximum of at least 24%, while protecting against losses up to 10%. Investors may lose up to 90% of their principal if the index declines beyond the 10% buffer.
What Marex Group Holders Got Right
Marex Group delivered a 71.4% return to shareholders in 2026, driven by record quarterly results and strategic acquisitions like Bright Point International. The article details how early investors had to weigh bullish arguments about expanding Prime Services and acquisitions against bearish concerns regarding compliance costs and automation. Ultimately, strong Q2 2026 results, including increased revenue and net income, validated the optimistic outlook for Marex Group.
Marex Group Limited (MRX) Seasonal returns chart
The article provides a seasonal returns chart for Marex Group Limited (MRX), showing average monthly price returns from 2024 to 2026. It also displays the current stock price and highlights trading activity during overnight sessions on the Blue Ocean ATS.
Marex Group Limited (MRX) Seasonal Returns Chart
The article presents a seasonal returns chart for Marex Group Limited (MRX), showing the average monthly price return from 2024 to 2026. It also provides real-time stock information, indicating that MRX closed at $68.38, up 5.36%, and shows its after-hours trading activity. Additionally, it announces the company's Q3 2026 earnings call scheduled for November 5, 2026.
MAEXF5930191 Bond Profile: Coupon and Redemption
This article provides a detailed profile of the MAEXF5930191 bond issued by Marex Group Limited. It outlines key facts such as the issue and maturity dates, face value, coupon rate, and payment schedule. The bond has a fixed rate of 6.40% paid semi-annually and an outstanding amount of $600 million USD.
Paying no interest, Marex Group (MRX)'s $355K notes put up to 100% of principal at risk.
Marex Group Limited has priced an offering of $355,000 in leveraged notes linked to the performance of Invesco QQQ Trust (QQQ) and State Street SPDR S&P 500 ETF Trust (SPY). These notes offer 150% participation in the gains of the weaker-performing ETF, but expose holders to a one-for-one decline and potential loss of up to 100% of their principal, with no interest payments. The notes are senior unsecured obligations and are subject to Marex's credit risk.
Marex (MRX) notes tied to Blackstone and Interactive Brokers Group can lose up to 100% of principal.
Marex Group Ltd (MRX) has set preliminary terms for autocallable contingent income buffered notes with a $1,000 principal amount per note, linked to the worst-performing of Interactive Brokers Group and Blackstone common stock and due May 18, 2028. These notes offer a contingent coupon rate of at least 2.005% per month but carry a significant risk: if not called, and the worst-performing stock falls below a 25% buffer, investors could lose up to 100% of their principal amount, with losses accelerating beyond the buffer. The estimated initial value of these notes is expected to be below their $1,000 public price.
A director with over 30 years of experience will join Marex Group (MRX) on November 2.
Marex Group Limited (MRX) has announced the appointment of Kory Sorenson to its Board of Directors, effective November 2, 2026. Ms. Sorenson brings over 30 years of experience in governance, financial strategy, and risk oversight, having held senior roles in insurance capital markets at Barclays Capital and Credit Suisse. Her expertise will be valuable as Marex continues its growth in global financial markets.
Marex appoints Kory Sorenson to Group Board
Marex Group Limited announced that Kory Sorenson will join its Group Board effective November 2, 2026. Sorenson brings over 30 years of experience in financial markets, governance, financial strategy, and risk oversight from various international organizations. Her appointment is expected to provide valuable expertise and insight as Marex continues its growth.
Marex (MRX) notes pay $7.09 monthly per $1,000, but investors may lose all principal.
Marex Group Ltd is offering $150,000 in fixed interest barrier notes linked to the worst-performing stock among Citigroup, Goldman Sachs, and JPMorgan Chase. These notes pay $7.09 monthly per $1,000 principal, regardless of stock performance, and mature on October 30, 2028. Investors face the risk of losing all principal if the worst-performing stock's Reference Return falls below -40.00%, as the notes do not participate in stock appreciation.
Up to 100% of principal is at risk on Marex (MRX) notes paying $20.17 monthly per $1,000.
Marex Group Ltd. is offering $539,000 in autocallable fixed income buffered notes linked to the worst-performing of Advanced Micro Devices and Palantir Technologies common stock. These notes pay $20.17 monthly per $1,000 principal, representing an annual rate of 24.204%, but investors risk losing up to 100% of their principal if the worst-performing stock declines beyond a 25% buffer, incurring approximately 133.33% downside leverage. The notes are senior unsecured debt and may be called early if both underlying stocks meet or exceed their initial values on observation dates, with an estimated initial value of $988 per note, below the public price of $1,000.
Should Proposed Settlement Notice Require Action From Marex Group (MRX) Investors?
A proposed class action settlement for purchasers of Marex Group plc ordinary shares has been approved for notice, with a fairness hearing set for February 2, 2027. This settlement puts Marex Group's legal and governance practices under scrutiny, potentially impacting future business execution and costs for investors. While not directly altering core operational catalysts like earnings quality and M&A, a cleaner legal backdrop could help management focus on integrating deals and maintaining client confidence.
Proposed notes from Marex Group (MRX) pay no interest and risk up to 100% principal loss.
Marex Group Ltd (MRX) has proposed an offering of senior unsecured notes linked to the performance of the Invesco QQQ Trust, Series 1 and the SPDR S&P 500 ETF Trust. These notes offer a 150% upside participation rate for positive returns but expose holders to a one-for-one reduction in principal for negative returns, with a potential loss of up to 100%. The notes pay no interest, and all payments are subject to Marex’s credit risk.
Marex Group (MRX) proposes $7.09 monthly payments per $1,000, with up to 100% principal risk.
Marex Group is proposing fixed-interest barrier notes linked to the performance of Citigroup, Goldman Sachs, and JPMorgan Chase common stock. These notes offer a monthly payment of $7.09 per $1,000 principal amount, equivalent to 8.508% per annum, but investors face up to 100% principal loss if the worst-performing stock declines by more than 40% from its initial value. The notes are senior unsecured obligations of Marex and their listing on the Vienna MTF is not guaranteed.
Can Marex Group (MRX) Stay Undervalued After Its Settlement Approval And New Chair?
Marex Group (MRX) is under investor scrutiny following a class action settlement approval and a new board Chair, despite recent share price cooling after a strong year-to-date performance. While one narrative suggests the stock is 12% undervalued based on analyst forecasts and improved productivity, another view, using a DCF model, indicates it might be overvalued. Investors are left to weigh these mixed signals and potential risks, such as acquisition integration and compliance costs, against the company's growth potential.
Can Marex Group (MRX) Stay Undervalued After Its Settlement Approval And New Chair?
Marex Group (MRX) is under investor scrutiny after a class action settlement and a new board Chair, following a strong year-to-date performance. While some narratives suggest the company is undervalued with a fair value of $79.88, a discounted cash flow model presents a more cautious view, valuing it at $49.34, leading to mixed signals for investors. The article encourages investors to weigh rewards and warning signs before making investment decisions.
Form 144 | Marex Group(MRX.US) Officer Proposes to Sell 4.82 Million in Common Stocks
A Marex Group (MRX.US) officer has filed a Form 144, indicating an intent to sell 4.82 million shares of common stock. This filing signals a significant proposed insider transaction for the company.
MAREX GROUP LTD (NASDAQ:MRX): High Growth Momentum and a Breakout Setup
MAREX GROUP LTD (NASDAQ:MRX) is highlighted as a stock with high growth momentum and a breakout setup, meeting specific criteria for strong earnings and sales growth, technical health, and consolidation patterns. The company exhibits robust EPS and sales growth, consistent earnings beats, and expanding profit margins, despite some uneven sales progression. Its strong technical ratings and a defined consolidation pattern suggest a potential breakout opportunity for investors.
Form 4 Marex Group Ltd: Paolo Tonucci (Officer) For: 12 October
The article reports on a Form 4 filing for Marex Group Ltd, indicating that Paolo Tonucci, an officer, made a transaction on October 12. This type of filing is used to disclose changes in beneficial ownership of a company's securities by insiders.
Form 4 Marex Group Ltd: Paolo Tonucci (Officer) For: 12 October
This article reports on a Form 4 filing for Marex Group Ltd, indicating that Paolo Tonucci, an officer, made a transaction on October 12. The brief notice highlights this insider activity for the company, which trades under the symbol MRX.
Under a 2025 trading plan, Marex Group (MRX) officer sells 16,666 shares.
Paolo Tonucci, Chief Strategist and CEO, Capital Markets of Marex Group Ltd (MRX), sold a total of 16,666 ordinary shares on October 12, 2026. These sales were conducted under a Rule 10b5-1 plan established on October 22, 2025. The shares were sold in two separate transactions at weighted average prices of $71.9819 and $72.6382 per share.
President Van Den Born Simon Sells 15,272 Shares of Marex Group Ltd (MRX)
President Van Den Born Simon of Marex Group Ltd (MRX) sold 15,272 shares on October 12, 2026, bringing his total sales over the past year to 57,072 shares with no purchases. This transaction is part of a broader trend of insider selling at Marex, with 17 insider sells and 0 buys over the last year, contrasting with 4 gurus holding shares, 3 of whom added to their positions. The company's valuation shows a P/E ratio of 12.93, which is below the industry median but above its historical median, leading to a mixed picture for investors.
Learn Why The Bull Case For Marex Group Stock Could Change Following Board Chair Appointment
Marex Group has appointed John Pietrowicz as its new Board Chair, signaling a heightened focus on mergers, acquisitions, and capital allocation. This change comes as former Chair Robert Pickering stepped down after completing his three-year term. Investors are keenly awaiting the upcoming fiscal 2026 third-quarter results on November 5th to assess the company's operational execution and how the new leadership's M&A focus might impact future growth and balance sheet risks.
Form 4 Marex Group Ltd: Paolo Tonucci (Officer) For: 12 October
This article reports on a Form 4 filing for Marex Group Ltd, indicating that officer Paolo Tonucci made a transaction on October 12th. Form 4 filings are regulatory documents that disclose changes in the ownership of securities by a company's officers, directors, and principal stockholders. The specific details of the transaction are not provided in this brief announcement.